# Cefepime/Enmetazobactam for Bacteremic Complicated Urinary Tract Infections

> **NCT07725848** · — · NOT_YET_RECRUITING · sponsor: **IRCCS Azienda Ospedaliero-Universitaria di Bologna** · enrollment: 200 (estimated)

## Conditions studied

- Complicated Urinary Tract Infections
- Antibiotic Resistance

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07725848
- **Lead sponsor:** IRCCS Azienda Ospedaliero-Universitaria di Bologna
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10-15
- **Primary completion:** 2028-04-30
- **Final completion:** 2029-10-15
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07725848

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07725848, "Cefepime/Enmetazobactam for Bacteremic Complicated Urinary Tract Infections". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07725848. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
